Tuesday, May, 17, 2022 01:11:31

Category: Pharmaceuticals

Perlara, Rambam Medical Center tie up for kidney disease PerlQuest

Perlara, the U.S. based biotech public benefit corporation that is dedicated to discovering cures for rare diseases, recently announced a partnership with Rambam Medical Center in Israel and Dr. Karl Skorecki, a leading kidney disease researcher and nephrologist, to co-develop a PerlQuest into APOL1 kidney disease. For …